Dr. Jonathan Shoag's laboratory at Case Western Reserve University has been awarded its second NIH R01 grant, one of the most competitive and prestigious forms of federal research funding. The new grant will support a longitudinal study examining how cancer treatment affects mutation rates in the male germline, tracking changes in sperm samples from cancer survivors before and after treatment.
This milestone reflects the lab's growing leadership in reproductive and cancer genomics research, and its continued commitment to improving fertility outcomes for cancer patients. The study is expected to generate insights that could shape future clinical guidance on fertility preservation for patients undergoing cancer therapy.